Researchers uncover 'hidden key' to immunotherapy for intractable brain tumors

Дата публикации: 20-07-2026 21:00:01

Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune "brakes" exploited by tumors to evade attack—show limited efficacy in some brain tumors. A KAIST research team found that B-cell and antibody responses initiated in tumor-draining lymph nodes, rather than T cells alone, are critical to the antitumor effects of anti-CTLA-4 therapy, opening a new avenue for treating intractable brain tumors.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	First-in-human immunotherapy more than doubles progression-free survival in glioblastoma patients	7	8	10-07-2026
2	Giving antibodies 'eyes' may help target hidden KRAS mutations in cancer cells	0	8.03	24-07-2026
3	Brain tumor vaccine links mutation targeting to eight-year survival gains	7	8	06-07-2026
4	Preoperative radiation may enhance brain metastases treatment	5	7	07-07-2026
5	New, improved method to find and isolate the strongest cancer-fighting immune cells	7	8	08-07-2026
6	Brain cancer may begin years before doctors can see it	0	9.69	28-01-2026
7	Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies	0	9.03	19-05-2026
8	New experimental approach may help overcome drug resistance in deadly brain cancer	5	8	09-07-2026
9	USC scientists just unlocked an endless supply of cancer-fighting immune cells	0	13.57	29-06-2026
10	CNIO to seek drugs to extend the effectiveness of immunotherapy to more tumors, using a strategy selected by the European Research Council	0	8.06	02-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 2. Информативность: 8. Источник: medicalxpress.com.